Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Abbott Laboratories
(NY:
ABT
)
104.09
-0.78 (-0.74%)
Official Closing Price
Updated: 7:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Abbott Laboratories
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
30
31
Next >
8 Dividend Aristocrats to Buy Now for a Lifetime of Passive Income
November 27, 2022
Dividend stocks are a great way to protect against a downturn and these are the cream of the crop.
Via
The Motley Fool
Is This Stock-Split Stock a Buy For 2023?
November 26, 2022
Don't buy this company's shares for its recent stock split.
Via
The Motley Fool
Better Dividend Stock: AbbVie or Viatris?
November 26, 2022
These pharmaceutical companies are profitable and offer above-average dividends.
Via
The Motley Fool
2 Unbeatable Dividend Stocks Billionaires Keep Buying in a Bear Market
November 25, 2022
Some of the world's most successful investors made big bets on these dividend payers recently.
Via
The Motley Fool
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years
November 24, 2022
Via
Benzinga
Could an Investment in AbbVie Give You $10,000 in Annual Dividend Income by Retirement?
November 23, 2022
This is a stock that rewards long-term investors through continual dividend increases.
Via
The Motley Fool
2 Reasons to Buy Abbott Labs and 1 Reason to Sell
November 17, 2022
The healthcare company offers growth and value.
Via
The Motley Fool
2 Stocks Down 75% and 26% to Buy Right Now
November 17, 2022
It's time to go bargain hunting.
Via
The Motley Fool
FDA Outlines Strategy To Review Infant Formula Production Rules
November 16, 2022
Via
Benzinga
Want $10,000 in Annual Dividend Income by Retirement? Here's How Much You Should Invest in AbbVie Today.
November 23, 2022
This is a stock that rewards long-term investors through continual dividend increases.
Via
The Motley Fool
AbbVie Boosts Its Dividend: Is the Dividend King a Buy?
November 23, 2022
Shares of the pharmaceutical stock have left the S&P 500 index in the dust so far this year.
Via
The Motley Fool
2 Reasons to Buy AbbVie Stock and 1 Reason to Sell
November 22, 2022
The pharmaceutical company's golden goose is about to stop laying golden eggs, but that won't be a permanent problem.
Via
The Motley Fool
Want Passive Income in 2023? Buy These Dividend Kings
November 22, 2022
These stocks offer you a gift: recurrent income just for owning them.
Via
The Motley Fool
7 No-Brainer Blue-Chip Stocks to Buy for 2023 and Beyond
November 12, 2022
With so many troubles ailing the economy and the broader market, investors should focus on these no-brainer blue-chip stocks to buy.
Via
InvestorPlace
3 Reasons to Buy AbbVie Stock Right Now
November 05, 2022
The drugmaker has something to offer to all kinds of investors.
Via
The Motley Fool
Is This Dividend King a Buy Near Its 52-Week Low?
October 28, 2022
Shares of this medical device and diagnostics stock have slumped in 2022.
Via
The Motley Fool
Here's How Much $1000 Invested In Abbott Laboratories 10 Years Ago Would Be Worth Today
November 10, 2022
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 1.79% on an annualized basis producing an average annual return of 12.9%. Currently, Abbott Laboratories has a...
Via
Benzinga
Better Buy: Johnson & Johnson vs. Abbott Laboratories
November 10, 2022
These two healthcare giants are among the safest stocks investors can buy right now.
Via
The Motley Fool
3 Top Healthcare Stocks Defying the Bear Market
November 10, 2022
These healthcare companies haven't been slowed by macroeconomic conditions.
Via
The Motley Fool
3 Food Processing Dividend Stocks That Could Benefit From Food Shortages Driven By Russia-Ukraine War
November 09, 2022
With global supply chain shortages impacting nearly every sector of the economy in the past two years, will global food shortages worsen? As the U.S.
Via
Benzinga
Got $1,000? 2 Bear Market Stocks to Jump On Right Now
November 08, 2022
Regardless of what the market does next, these top stocks have a much longer growth trajectory ahead.
Via
The Motley Fool
Investing $1,000 in the Current Market? Don't Overlook These 2 Winning Dividend Stocks
November 08, 2022
Just because the stock market is going haywire doesn't mean you have to sit on the sidelines.
Via
The Motley Fool
2 Reasons to Buy DexCom, and 1 Reason to Sell
November 07, 2022
Do the potential benefits outweigh the risks?
Via
The Motley Fool
Targeting Autosomal Dominant Polycystic Kidney Disease With Novel Approaches
November 03, 2022
Approximately 160,000 individuals in the United States are diagnosed with polycystic kidney disease, and the global prevalence of the condition is estimated at between 4 million and 7 million people.
Via
Benzinga
Got $5,000? Buy These 3 Dividend Kings And Hold Them Forever
November 02, 2022
These healthcare companies should stay relevant for years as they continue to innovate with new products.
Via
The Motley Fool
Is DexCom a Good Healthcare Stock to Buy Now?
November 02, 2022
After rising about 50% in October, investors want to know if this stock still has any fuel in the tank.
Via
The Motley Fool
3 Dividend-Paying Stocks to Buy in November and Hold Forever
November 02, 2022
Adding these stocks to your portfolio could lead to a lifetime of passive income.
Via
The Motley Fool
This Groundbreaking Device Just Keeps Winning for Abbott Labs
November 01, 2022
Its continuous glucose monitor has proven immensely effective in helping type 2 diabetes patients.
Via
The Motley Fool
Looking Into Abbott Laboratories's Recent Short Interest
October 27, 2022
Abbott Laboratories's (NYSE:ABT) short percent of float has fallen 16.33% since its last report. The company recently reported that it has 13.99 million shares sold short, which is 0.82% of all regular...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022
October 26, 2022
Upgrades
Via
Benzinga
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
30
31
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.